Springer Health IME, providing independent medical education in Neurology, Diabetes, Oncology, Rare Diseases, Endocrinology, and Paediatrics.

Joined March 2016
833 Photos and videos
This Myasthenia Gravis Awareness Month, join Dr. Kelly Gwathmey in a free, CME-accredited eLearning program to explore the value of a patient-centric approach to generalized myasthenia gravis (gMG): go.sn.pub/zv9fsr
32
1
12
17,009
With #ADA2026 right around the corner, now’s the perfect time to familiarize yourself with the latest in ketone monitoring with our free, CME-accredited masterclass series; designed to enhance your confidence and decision-making: go.sn.pub/c49u8c
3
2
5
8,948
Led by Dr. Vaishali Sanchorawala and Prof. Sebastian Spethmann, our free, interactive case files provide practical insights into building a sustainable MDT amyloidosis care framework, from streamlining care coordination to reducing diagnostic delays: go.sn.pub/496udh
2
3
3,919
Get ready for #EULAR2026 and explore novel strategies in the management of systemic lupus erythematosus (SLE) with our expert-led video series, now complete with a quick-reference infographic summary to support your clinical decision-making: go.sn.pub/uyjhcp
2
1
8
4,670
Prof. Carola Dröge and Prof. Verena Keitel-Anselmino speak live from #EASLCongress, discussing IBAT inhibitor therapy in adults with hereditary BSEP-deficiency. Watch the full video: rare-liver-disorders.ime.spr…
3
2
6
5,369
Breaking from #EASLCongress: Observational data show IBAT inhibitor promise for pruritus in late-onset PFIC and ICP. Read the full story: rare-liver-disorders.ime.spr…
4
3,557
Live from #EASLCongress: Intrahepatic cholestasis of pregnancy recurs in 4 in 10 pregnancies. Get the full story: rare-liver-disorders.ime.spr…
1
1,878
Dr Jeremy Nayagam speaks live from #EASLCongress 2026, highlighting research on genetic testing in adults with unexplained cholestatic liver disease and hepatitis. Watch the full video now, and explore our coverage of the congress: rare-liver-disorders.ime.spr…
2
10
17
2,307
Live from #EASLCongress: Case series suggests IBAT inhibitor benefits in adults with hereditary BSEP deficiency. Read the full story: rare-liver-disorders.ime.spr…
1
1,016
Breaking from #EASLCongress: Targeted gene sequencing panel resolves unexplained cholestasis in about 5% of adults. Get the full story: rare-liver-disorders.ime.spr…
1
19
23
4,887
Heading to #ASCO2026? Catch up on the latest therapeutic approaches for mycosis fungoides-type cutaneous T-cell lymphoma in our free, CME-accredited webcast. Start watching and prepare for meaningful peer-to-peer conversations at ASCO: go.sn.pub/8cum0b
1,046
Breaking from #EASLCongress: Genetic variants explain substantial proportion of undiagnosed cholestasis and hepatitis. Find out more: rare-liver-disorders.ime.spr…
727
Live from #EASLCongress: Bilirubin and platelet count predict native liver survival in adolescents with ALGS. Read the full story: rare-liver-disorders.ime.spr…
738
Live from #EASLCongress: Researchers call for ICP to be included in hepatobiliary risk stratification. Read the full story here: rare-liver-disorders.ime.spr…
1,062
Navigating neuroimaging in Alzheimer’s care: Put your PET tracer selection and interpretation skills into practice using our Case Challenge series. Get started for free and strengthen your diagnosis, disease staging, and treatment decision-making: go.sn.pub/xfeomg
731
Are you at #EASLCongress in Barcelona? Stop by Booth C04 to find out more about our key IME programs in rare liver disorders.
We're here at #EASLCongress in Barcelona! Stop by Booth C04 to find out more about Springer Medicine, our free medical education platform, as well as our key IME programs in hepatology 🎯
1
3
6,311
Looking for key information on the utility of biomarkers, interpretation of biomarkers, and use of biomarkers for treatment selection in an easy-to-use, downloadable format? Build your own infographic, and tailor the insights to your clinical practice: alzheimers-biomarkers-mdt.im…
1
7
3,625
In our free, three-part video podcast series, hosted by @Dr_AmerZeidan, hear directly from the experts on genetic testing and diagnostics, emerging targeted therapies, and personalized treatments in relapsed/refractory (R/R) AML: go.sn.pub/a1xprh
1
6
3,497
Unpick the role of the tumor microenvironment in mycosis fungoides-type cutaneous T-cell lymphoma in our free, CME-accredited webcast, led by Dr. Larisa J. Geskin. Start watching to sharpen your focus and apply the latest insights to your practice: go.sn.pub/tr1exh
4
9
4,666
From emerging therapies to tactics for multidisciplinary collaboration, our free, CME-accredited video podcast series led by Dr Kelly Gwathmey combines expert insights with scientific data to help clinicians deliver an optimized gMG care strategy: go.sn.pub/ptpq88
2
4
16
3,717